PREVIOUS
✖
NexCAR 19
October 22 , 2023
401 days
1853
0
- ImmunoACT, an IIT-Bombay incubated startup, had developed a CAR-T Cell Therapy drug named NexCAR 19 for cancer therapy.
- CAR-T Cell Therapy is an innovative form of cancer treatment that involves genetically modifying a patient's T cells to fight cancer cells.
- NexCAR 19 is intended for the treatment of lymphomas and leukaemia, which are types of blood cancers.
Leave a Reply
Your Comment is awaiting moderation.